Abstract
The transcription factor E2F1 mRNA and protein levels increased in rat cortical neurons in response to dopamine (DA)- or 6-hydroxydopamine (OHDA)-evoked apoptosis. Increased E2F1 protein was detected in the nucleus of neurons by double fluorescent immunocytochemistry using antibodies to E2F1 and NeuN. DA and 6-OHDA induced caspase-3-mediated apoptosis of cortical neurons which was attenuated by the addition of antioxidants or caspase-3 inhibitors to the cultures. Antioxidants prevented DA-evoked neuronal apoptosis, and also attenuated the increase in E2F1 expression. These findings suggest that increased expression of the transcription factor E2F1 may serve as a death signal during DA-evoked neuronal apoptosis.
MeSH terms
-
Animals
-
Antioxidants / pharmacology
-
Apoptosis / drug effects
-
Apoptosis / physiology*
-
Carrier Proteins*
-
Caspase 3
-
Caspase Inhibitors
-
Caspases / metabolism*
-
Cell Cycle Proteins*
-
Cerebral Cortex / cytology
-
Cysteine Proteinase Inhibitors / pharmacology
-
DNA-Binding Proteins*
-
Dopamine / pharmacology*
-
E2F Transcription Factors
-
E2F1 Transcription Factor
-
Gene Expression / physiology
-
Neurons / cytology*
-
Neurons / enzymology
-
Oligopeptides / pharmacology
-
RNA, Messenger / analysis
-
Rats
-
Rats, Sprague-Dawley
-
Retinoblastoma-Binding Protein 1
-
Transcription Factors / genetics*
Substances
-
Antioxidants
-
Carrier Proteins
-
Caspase Inhibitors
-
Cell Cycle Proteins
-
Cysteine Proteinase Inhibitors
-
DNA-Binding Proteins
-
E2F Transcription Factors
-
E2F1 Transcription Factor
-
E2f1 protein, rat
-
Oligopeptides
-
RNA, Messenger
-
Retinoblastoma-Binding Protein 1
-
Transcription Factors
-
benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone
-
Casp3 protein, rat
-
Caspase 3
-
Caspases
-
Dopamine